PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsStreptomycin
Streptomycin
Streptomycin (streptomycin) is a small molecule pharmaceutical. Streptomycin was first approved as Streptomycin sulfate on 1982-01-01. It is used to treat bacterial endocarditis, brucellosis, chancroid, escherichia coli infections, and granuloma inguinale amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
urogenital diseasesD000091642
cardiovascular diseasesD002318
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Streptomycin (discontinued: Streptomycin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
streptomycinANDA2026-01-21
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
urinary tract infectionsEFO_0003103D014552N39.0
escherichia coli infectionsEFO_1001318D004927B96.20
streptococcal infectionsEFO_1001476D013290—
bacterial endocarditisEFO_1000830D004697—
proteus infectionsEFO_1001130D011512—
brucellosisEFO_0007185D002006A23
plagueEFO_0007481D010930A20
klebsiella infectionsEFO_1001353D007710—
mycobacterium infections—D009164A31.9
tularemiaEFO_1001444D014406A21
Show 2 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07A: Intestinal antiinfectives
— A07AA: Antibiotics, intestinal
— A07AA04: Streptomycin
— A07AA54: Streptomycin, combinations
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01G: Aminoglycoside antibacterials
— J01GA: Streptomycins
— J01GA01: Streptomycin
— J04: Antimycobacterials
— J04A: Drugs for treatment of tuberculosis
— J04AM: Combinations of drugs for treatment of tuberculosis
— J04AM01: Streptomycin and isoniazid
HCPCS
Code
Description
J3000
Injection, streptomycin, up to 1 gm
Clinical
Clinical Trials
32 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
TuberculosisD014376EFO_0000774A15-A19131149
Pulmonary tuberculosisD014397EFO_1000049A15—1—135
Multidrug-resistant tuberculosisD018088EFO_0007381——1—1—2
Stem cell researchD057905—————2—2
KeloidD007627EFO_0004212L91.0———2—2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mycobacterium avium-intracellulare infectionD015270EFO_0007386——1———1
DengueD003715—A90—1———1
FrailtyD000073496—R53.111———1
Human influenzaD007251EFO_0007328J11.111———1
Haemophilus influenzaeD006193NCBITaxon_727B96.311———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteomyelitisD010019EFO_0003102M861————1
Healthy volunteers/patients———1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Aids-related opportunistic infectionsD017088——————11
Diabetes mellitusD003920EFO_0000400E08-E13————11
Gestational diabetesD016640—O24.4————11
Inborn errors metabolismD008661——————11
Diabetic neuropathiesD003929EFO_1000783—————11
Immune system diseasesD007154—D89.9————11
Communicable diseasesD003141——————11
Bacterial infectionsD001424—A49————11
Rare diseasesD035583——————11
Spontaneous abortionD000022EFO_1001255O00.1————11
Show 5 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameStreptomycin
INNstreptomycin
Description
Streptomycin is a amino cyclitol glycoside that consists of streptidine having a disaccharyl moiety attached at the 4-position. The parent of the streptomycin class It has a role as an antimicrobial agent, an antimicrobial drug, an antibacterial drug, a protein synthesis inhibitor, a bacterial metabolite and an antifungal agrochemical. It is an antibiotic antifungal drug, an antibiotic fungicide and a member of streptomycins. It is functionally related to a streptidine. It is a conjugate base of a streptomycin(3+).
Classification
Small molecule
Drug classantibiotics (Streptomyces strain)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O
Identifiers
PDB—
CAS-ID57-92-1
RxCUI—
ChEMBL IDCHEMBL372795
ChEBI ID17076
PubChem CID19649
DrugBankDB01082
UNII IDY45QSO73OB (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 578,715 documents
View more details
Safety
Black-box Warning
Black-box warning for: Streptomycin
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
842 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use